31 August 1998 00:00 [Source: ICB]
Novo Nordisk has received marketing approval in the European Union (EU) for its NovoNorm (repaglinide) diabetes treatment. The company said it expected to launch the product in a number of EU countries by the end of this year.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
Sample issue >>
My Account/Renew >>
Register for online access >>
|ICIS Top 100 Chemical Companies|
|Download the listing here >>|